Assistant professor of pharmaceutics and bioengineering
Thousands of lives are lost each year to breast cancer, ovarian cancer and leukemia. If Seungpyo Hong can save just one life, he considers his work a success.
Hong combines nanotechnology and biomimetics to create new forms of polymer-based nanomaterials to detect circulating tumor cells and create artificial surfaces to remove the damaged cells from the blood. The dendrimer-based nanocarriers provide a platform technology for targeted delivery of multiple drugs to cancer cells.
Hong is developing a topical drug delivery system containing endoxifen that may prevent breast cancer. Dendron-based micelles are used to encapsulate endoxifen, the most commonly used hormone therapy for the disease. By delivering the drug directly to the site of the potential cancer, mastectomies and severe side effects caused by endoxifen could be reduced.
His research funding includes support from the National Science Foundation and the Susan G. Komen Foundation.
- Cancer prevention
In the News
July 10, 2014